Find therapies in clinical trials near you – page 65

Study of Brentuximab Vedotin, Adriamycin, Vinblastine, and Dacarbazine for Children with Advanced Stage Hodgkin Lymphoma

Study on Frexalimab for Treating Active Systemic Lupus Erythematosus in Patients

Study on Frexalimab for Treating Active Systemic Lupus Erythematosus in Patients

Study on Sibeprenlimab for Patients with IgA Nephropathy

Study on Sibeprenlimab for Patients with IgA Nephropathy

Study of CGT9486 and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors

Study of CGT9486 and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors

Study on Ertugliflozin for Children and Teens with Type 2 Diabetes

Study on Ertugliflozin for Children and Teens with Type 2 Diabetes

Study on the Safety and Effectiveness of Stereotactic Body Radiotherapy with or without Pembrolizumab for Patients with Unresected Stage I or II Non-Small Cell Lung Cancer

Study on the Safety and Effectiveness of Stereotactic Body Radiotherapy with or without Pembrolizumab for Patients with Unresected Stage I or II Non-Small Cell Lung Cancer

Study of EQU-001 and Placebo for Patients with Uncontrolled Focal Seizures in Epilepsy

Study of EQU-001 and Placebo for Patients with Uncontrolled Focal Seizures in Epilepsy

Study on MK-7684A and Docetaxel for Treating Metastatic Non-Small Cell Lung Cancer in Patients After Platinum Chemotherapy and Immunotherapy

Study on MK-7684A and Docetaxel for Treating Metastatic Non-Small Cell Lung Cancer in Patients After Platinum Chemotherapy and Immunotherapy

Study on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis

Study on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis

Study on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months

Study on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months

Study on the Effectiveness and Safety of Oral Azacitidine for Patients with Low or Intermediate-Risk Myelodysplastic Syndrome

Study of Zilovertamab Vedotin with Drug Combination for Patients with Diffuse Large B-Cell Lymphoma

Study of Zilovertamab Vedotin with Drug Combination for Patients with Diffuse Large B-Cell Lymphoma